InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Hunt Anthony, Chairman & CEO. Director active across 4 companies, notably Repligen CORP. Cumulatively, 41 disclosures have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €1.3m. History available since 19 May 2021. The latest transaction was filed on 15 May 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations41 total
2,043 shares@ US$122.662.5% of flowCommon StockSEC:0000950170-25-073387:0
6,876 sharesCommon StockSEC:0001628280-25-014190:0
5,000 shares@ US$33.871.7% of flowCommon StockSEC:0000950170-25-042026:0
10,142 shares@ US$155.3816.7% of flowCommon StockSEC:0000950170-25-031572:0
2,058 sharesCommon StockSEC:0001562180-25-002060:0
2,825 shares@ US$156.544.7% of flowCommon StockSEC:0000950170-25-030051:0
2,380 shares@ US$164.744.1% of flowCommon StockSEC:0000950170-25-026171:0
11,808 shares@ US$33.874.2% of flowCommon StockSEC:0000950170-24-133812:0
24,246 shares@ US$33.878.6% of flowCommon StockSEC:0000950170-24-130266:0
10,000 shares@ US$33.873.4% of flowCommon StockSEC:0000950170-24-105742:0
13,146 shares0Common StockSEC:0000950170-24-103577:0
2,000 shares@ US$124.082.6% of flowCommon StockSEC:0000950170-24-073836:0
Ideal exit: 11 Mar 2025 (T+270)
7,777 sharesCommon StockSEC:0001562180-24-005063:0
4,274 shares@ US$166.367.2% of flowCommon StockSEC:0000950170-24-063594:0
2,000 shares0Common StockSEC:0000950170-24-034204:0
1 shares@ US$16.550.0% of flowCommon StockSEC:0000950170-24-029523:0
2,867 shares@ US$195.725.7% of flowCommon StockSEC:0000950170-24-028016:0
1,111 shares@ US$193.992.2% of flowCommon StockSEC:0000950170-24-027514:0
2,057 sharesCommon Stock, par value $0.001SEC:0001562180-24-002324:0
2,504 shares0Common StockSEC:0000950170-24-025302:0
19,719 shares0Common StockSEC:0000950170-24-023489:0
1,000 shares0Common StockSEC:0000950170-23-064504:0
4,771 sharesCommon StockSEC:0001562180-23-005308:0
2,058 sharesCommon Stock, par value $0.001SEC:0001562180-23-002561:0
19,393 shares0Common StockSEC:0000899243-23-007194:0
25 of 41 declarations
About Hunt Anthony
Anthony Hunt is the Chief Executive Officer of Repligen Corp. He leads the company in its efforts to develop innovative solutions in the biotechnology field, focusing on improving drug manufacturing and purification processes.
